The drug regulator has approved Covovax as a heterologous booster dose for adults administered with two doses of Covishield or Covaxin, sources said.
Read More News on
(Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
